Table 1.
In silico study of putative molecular residual interactions between recombinant Fel d 1 (rFel d 1) and the compounds and assessment of their capabilities to displace N-phenyl-1-naphthylamine (1-NPN).
n° | Compound Names | Estimated Free Energy of Binding (kcal/mol) | Total Intermolecular Energy (kcal/mol) | Frequency | H-Bond Residue | Hydrophobic Residue (Alkyl/Pi-Alkyl/Pi-Sigma) | In Silico Screening a | 1-NPN Displacement Screening |
---|---|---|---|---|---|---|---|---|
Fatty Acids and Other Derivatives | ||||||||
1 | Isobutyric acid | −2.96 | −3.26 | 27% | A88, Y119, L129 | No | ND | |
2 | Capric Acid | −5.16 | −7.4 | 23% | L61, F80, V83, F84 | No | No | |
3 | Lauric Acid | −5.84 | −8.58 | 60% | Y119 | L61, F80, V83, F84 | Yes | Yes |
4 | Myristic Acid | −3.35 | −7.02 | 36% | F84 | F13, V133, M134, I137 | Yes | Yes |
5 | Palmitic Acid | −2.33 | −5.88 | 16% | F84 | V133, M134 | Yes | Yes |
6 | Oleic Acid | −2.82 | −7.05 | 50% | M134 | I64, F80, V83 | Yes | Yes |
7 | Linoleic Acid | −2.95 | −6.88 | 40% | P78 | A88, Y119, L129 | Yes | Yes |
8 | Dodecanal | −4.88 | −7.42 | 2% | F84, M134 | No | No | |
9 | Dodecanol | −3.93 | −7.02 | 2% | F84, V133, M134 | No | No | |
10 | Tetradecanol | −3.97 | −7.89 | 6% | P78, Y81 | No | No | |
11 | Ethyl Laurate | −4.7 | −8.02 | 12% | F84 | L61, I64, F80, V83, V133, M134, I137 | Yes | No |
12 | Methyl Palmitate | −2.53 | −6.67 | 20% | T76 | Yes | No | |
13 | Nonanamide | −4.53 | −6.51 | 4% | L61, I64, V83, F80 | No | ND | |
14 | Hexadecanamide | −2.84 | −6.3 | 18% | T135 | Y81 | Yes | ND |
15 | Octadecanamide | −2.81 | −6.96 | 6% | G131 | Y81, F85 | Yes | ND |
Steroids | ||||||||
1 | Androstenone | −5.84 | −5.84 | 65% | S138 | P78, Y81, F85 | Yes | Yes |
2 | Androstenedione | −5.83 | −5.83 | 44% | Y81, F85 | Yes | Yes | |
3 | Androstenol | −5.06 | −5.36 | 22% | Y81, F85 | No | No | |
4 | Progesterone | −5.74 | −6.04 | 62% | T76 | Y81, F85 | Yes | Yes |
5 | Hydroxyprogesterone | −5.14 | −5.54 | 39% | Y81 | F85 | Yes | Yes |
6 | Pregnenolone | −5.59 | −6.17 | 58% | T76 | Y81, F85 | Yes | Yes |
7 | Estradiol | −4.94 | −5.54 | 26% | T76 | Y81, F85 | Yes | Yes |
8 | Testosterone | −5.6 | −5.9 | 35% | T76 | Y81, F85 | Yes | Yes |
9 | Dihydrotestosterone | −5.06 | −5.35 | 12% | Y81, F85 | No | No | |
10 | Estrone | −3.56 | −3.86 | 10% | D82, G131 | F85 | Yes | Yes |
11 | Dehydroepiandrosterone (DHEA) | −4.64 | −4.94 | 30% | Y81, F85 | Yes | Yes | |
12 | Corticosterone | −5.35 | −6.38 | 30% | T76, N89 | Y81, F85 | Yes | No |
13 | Deoxycorticosterone | −4.99 | −5.29 | 12% | Y81, F85 | No | No | |
Fluorescent Probe | ||||||||
1 | 1-NPN (Central) | −6.7 | −7.41 | 50% | Y119 | L14, L61, M112 | Yes | / |
2 | 1-NPN (Surface) | −4.74 | −5.45 | 30% | Y81, F85 | Yes | / |
ND: Not determined because of the fluorescence increase, probably due to non-specific hydrophobic interactions [42]. a The in silico screenings were considered to result in positive outcomes (“yes”) if the following were predicted: (1) minimum one H-bond interaction irrespective of the binding frequency or (2) ≥30% of binding frequency without H-bond. This threshold value of binding frequency (≥30%) was selected from the minimum binding frequency of the fluorescent probe (1-NPN) with rFel d 1.